Summary by Moomoo AI
On September 18, 2024, CanSino Biologics held the 2024 Pharmaceuticals and Biopharmaceuticals Performance Presentation in the form of an online interactive text session at the Shanghai Stock Exchange Listing Roadshow Center. The purpose of this presentation is to provide investors with a more comprehensive understanding of the company's performance and financial condition in the first half of the year. The company released its semi-annual report on August 30 and answered questions of concern to investors during the presentation. Attendees included Mr. Yu Xuefeng, Chairman and CEO of the company, Mr. Cui Jin, Board Secretary, and Mr. Liu Ming, Acting Chief Financial Officer. Investors had the opportunity to submit their questions to the designated email address before 4:00 PM on September 17, the day before the presentation, in order to receive answers during the event.
